News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Incyte
NEWS
JOBS
IN THE PRESS
NEWS
Business
Q&A With Incyte CEO: Working Hard To Support R&D
April 28, 2016
·
1 min read
Deals
Three Potential Takeover Targets for Amgen
March 10, 2016
·
3 min read
Drug Development
Incyte Stock Tumbles After Halting Another Jakafi Trial for Treating Solid Tumors
February 11, 2016
·
3 min read
Drug Development
Incyte Plunges on Halted Colorectal Cancer Study
January 28, 2016
·
2 min read
Job Trends
Incyte to Hire 400 as Delaware Officials Mull Possibilities of Attracting More Health Science Companies
November 16, 2015
·
3 min read
Business
Incyte Reorganizes and Shakes Up Management to Drive Growth
June 19, 2015
·
2 min read
Business
Incyte Targets Switzerland for a New Clinical Development HQ
April 14, 2015
·
2 min read
Business
Incyte Corporation, Agenus Strike $410 Million+ Immuno-Oncology Antibodies Pact
January 9, 2015
·
2 min read
Drug Development
Eli Lilly, Incyte Corporation Arthritis Drug Meets Endpoint In Phase 3
December 9, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
January 28, 2026
·
1 min read
Press Releases
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma
January 5, 2026
·
9 min read
Press Releases
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
December 23, 2025
·
7 min read
Press Releases
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
December 23, 2025
·
7 min read
Press Releases
Incyte to Present at Upcoming Investor Conference - December 18, 2025
December 19, 2025
·
1 min read
Press Releases
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma
December 18, 2025
·
9 min read
Press Releases
Incyte Announces Change to its Board of Directors
December 15, 2025
·
1 min read
Press Releases
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia
December 9, 2025
·
10 min read
Press Releases
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
December 8, 2025
·
17 min read
Press Releases
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
December 8, 2025
·
6 min read
